Cat.#: ACPP-1196
| Despition | Insulin Receptor beta Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1431 | Human CNTFR Protein (AC1431) | 5 µg | inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
| ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1412 | Human SLC4A4 Protein (AC1412) | 5 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.